These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24654599)

  • 1. The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans.
    Wang H; Raleigh DP
    Biochemistry; 2014 Apr; 53(16):2605-14. PubMed ID: 24654599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.
    Meng F; Raleigh DP
    J Mol Biol; 2011 Feb; 406(3):491-502. PubMed ID: 21195086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes.
    Meng F; Abedini A; Song B; Raleigh DP
    Biochemistry; 2007 Oct; 46(43):12091-9. PubMed ID: 17924651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets.
    Paulsson JF; Andersson A; Westermark P; Westermark GT
    Diabetologia; 2006 Jun; 49(6):1237-46. PubMed ID: 16570161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall sulfation of heparan sulfate from pancreatic islet β-TC3 cells increases maximal fibril formation but does not determine binding to the amyloidogenic peptide islet amyloid polypeptide.
    Hull RL; Peters MJ; Perigo SP; Chan CK; Wight TN; Kinsella MG
    J Biol Chem; 2012 Oct; 287(44):37154-64. PubMed ID: 22936797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide.
    Courtade JA; Wang EY; Yen P; Dai DL; Soukhatcheva G; Orban PC; Verchere CB
    Diabetologia; 2017 Mar; 60(3):453-463. PubMed ID: 27999871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substoichiometric Inhibition of Insulin against IAPP Aggregation Is Attenuated by the Incompletely Processed N-Terminus of proIAPP.
    Benhamou Goldfajn N; Tang H; Ding F
    ACS Chem Neurosci; 2022 Jul; 13(13):2006-2016. PubMed ID: 35704461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro.
    Exley C; House E; Patel T; Wu L; Fraser PE
    J Inorg Biochem; 2010 Oct; 104(10):1125-9. PubMed ID: 20579740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro.
    Higham CE; Hull RL; Lawrie L; Shennan KI; Morris JF; Birch NP; Docherty K; Clark A
    Eur J Biochem; 2000 Aug; 267(16):4998-5004. PubMed ID: 10931181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.
    Hull RL; Zraika S; Udayasankar J; Kisilevsky R; Szarek WA; Wight TN; Kahn SE
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1586-93. PubMed ID: 17804609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet amyloid polypeptide and type 2 diabetes.
    Marzban L; Park K; Verchere CB
    Exp Gerontol; 2003 Apr; 38(4):347-51. PubMed ID: 12670620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions.
    Tu LH; Young LM; Wong AG; Ashcroft AE; Radford SE; Raleigh DP
    Biochemistry; 2015 Jan; 54(3):666-76. PubMed ID: 25531836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site.
    Wang J; Xu J; Finnerty J; Furuta M; Steiner DF; Verchere CB
    Diabetes; 2001 Mar; 50(3):534-9. PubMed ID: 11246872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation.
    Abedini A; Tracz SM; Cho JH; Raleigh DP
    Biochemistry; 2006 Aug; 45(30):9228-37. PubMed ID: 16866369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP).
    Krampert M; Bernhagen J; Schmucker J; Horn A; Schmauder A; Brunner H; Voelter W; Kapurniotu A
    Chem Biol; 2000 Nov; 7(11):855-71. PubMed ID: 11094339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions.
    Wang H; Cao P; Raleigh DP
    J Mol Biol; 2013 Feb; 425(3):492-505. PubMed ID: 23154166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells.
    Marzban L; Soukhatcheva G; Verchere CB
    Endocrinology; 2005 Apr; 146(4):1808-17. PubMed ID: 15618358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.
    Park K; Verchere CB
    J Biol Chem; 2001 May; 276(20):16611-6. PubMed ID: 11145957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions.
    Susa AC; Wu C; Bernstein SL; Dupuis NF; Wang H; Raleigh DP; Shea JE; Bowers MT
    J Am Chem Soc; 2014 Sep; 136(37):12912-9. PubMed ID: 25144879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.